CEP57L1 and cancer: Cancer tissues had lower levels of KLF5, KLHL13, and CUL3 but higher levels of CEP57L1 than paracarcinoma counterparts (Figs. 8F and S8A), which was exaggerated by the presence of diabetes (Fig. S8, B and C).